Patents Assigned to BlueValley Pharmaceutical LLC
  • Substituted pyrrolopyridines as ATR inhibitors
    Patent number: 11236089
    Abstract: The disclosure includes compounds of Formula (I) wherein A, W, m, R5, R6, R7, and R8, are defined herein. Also disclosed is a method for treating a neoplastic disease with these compounds.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: February 1, 2022
    Assignee: BlueValley Pharmaceutical LLC
    Inventor: Xiang Li